Condition: Heart Failure · Cardiovascular Diseases · Sponsor: NHS Greater Glasgow and Clyde
This is an international prospective, multicentre, unblinded, randomised-controlled trial. The primary aim is to assess a targeted screening strategy to detect undiagnosed heart failure in high-risk patients.
This description comes directly from the study's public registry record.
Mark C Petrie, MbChB · +44(0) 141 330 2677 · mark.petrie@glasgow.ac.uk
Kieran F Docherty, MbChB · +44(0) 141 330 2677 · kieran.docherty@glasgow.ac.uk
Always discuss trial participation with your own doctor first.
| Cleveland Clinic | Cleveland, Ohio, United States | Not Yet Recruiting |
| University of British Columbia | Vancouver, British Columbia, Canada | Not Yet Recruiting |
| University of Montreal | Montreal, Quebec, Canada | Not Yet Recruiting |
| Rigshospitalet, Copenhagen University Hospital | Copenhagen, Denmark | Not Yet Recruiting |
| Karolinska University Hospital | Stockholm, Sweden | Not Yet Recruiting |
| Uppsala University | Uppsala, Sweden | Not Yet Recruiting |
| University of Glasgow | Glasgow, Scotland, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05919342